Patho Exam 1 Flashcards
Pharmacokinetics (4)
Effect of the body on drugs
Absorption
Distribution
Metabolism
Excretion
Weak acid is a….
….proton donator
Weak base is a….
….proton acceptor
Ionization is…
…when an acid or base becomes a charged particle. Can no longer cross membranes!
Two forms of drug administration (broad)
Enteral, Parenteral
Enteral forms of administration (3)
Oral
Rectal (erratic absorption)
Sublingual/buccal (bypasses first pass effect)
Parenteral forms of administration (6)
IV IM Sub-q Transdermal Inhalation Other (topical)
1st pass effect
Oral drugs! Decrease the amount available to the body.
Bioavailability
Fraction of the dose that reaches systemic circulation. With IV = 100%
Distribution issues (3)
Blood brain barrier
Placenta
Breastmilk
Plasma protein binding
Plasma in the blood (albumin) binds to the drug, rendering it inactive. Reversible. Affected by nutritional status, plasma protein levels.
Elimination is affected by….
….renal/hepatic function, medications, genetics, age
Metabolism one word definition
Biotransformation!
Where does metabolism occur?
Liver, GI tract, lungs, skin, kidneys. Via enzymes.
What is a pro-drug?
A drug that is inactive until it undergoes metabolism to an active form
What is a metabolite?
The product of biotransformation
Renal Excretion (3)
- Glomerular Filtration - drugs go from blood to urine
- Passive tubular reabsorption - lipophilic things go back in to the body, while ions/polar compounds stay in the urine
- Active secretion - active transport systems remove organic acids and bases
Schedules of drugs
- Schedule 1 is fun (aka illegal, only recreational), schedule 5 is lowest likelihood for abuse.
Steps of new drug development
Pre-Clinical (on animals, studying toxicology, PK, pharmacology)
IND (Investigational New Drug application)
Clinical (Phase 1-3)
NDA (New Drug Application)
Marketing (Phase 4, post-marketing surveillance for low incidence adverse effects)
Clinical Phases 1-3 of new drug development
Phase 1: on healthy individuals, testing PK, safety, dose. n=20-80
Phase 2: testing effects and safety. n=100-300
Phase 3: testing safety/effectiveness. Rigorous design, randomized double blind trials, placebo effects. n=100-3000
Pharmacodynamics is….
…the study of the drug on the body
Pharmacologic effects (2)
Therapeutic
Toxic
Factors of drug response (3)
Administration: med errors, pt adherence
Pharmacokinetics: absorption, distribution, metabolism, excretion
Pharmacodynamics: drug-receptor interaction, pt functional state, placebo effects
Types of receptors (4)
Cell membrane embedded
Ligand-gated ion channels
G-protein coupled
Transcription factors